IKKBETA Gene
Introduction <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">IKKBETA Gene</th> </tr> <tr> <td class="label">Gene Symbol</td> <td>IKBKB</td> </tr> <tr> <td class="label">Alternate Symbols</td> <td>IKKβ, IKK2</td> </tr> <tr> <td class="label">Full Name</td> <td>Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta</td> </tr> <tr> <td class="label">Chromosomal Location</td> <td>8p11.21</td> </tr> <tr> <td class="label">NCBI Gene ID</td> <td>3551</td> </tr> <tr> <td class="label">Ensembl ID</td> <td>ENSG00000105220</td> </tr> <tr> <td class="label">UniProt ID</td> <td>O14920</td> </tr> <tr> <td class="label">RefSeq mRNA</td> <td>NM_001190</td> </tr> <tr> <td class="label">Protein Length</td> <td>756 amino acids</td> </tr> <tr> <td class="label">Compound</td> <td>Stage</td> </tr> <tr> <td class="label">Bay 11-7082</td> <td>Preclinical</td> </tr> <tr> <td class="label">MLN120B</td> <td>Preclinical</td> </tr> <tr> <td class="label">PS-1145</td> <td>Preclinical</td> </tr> <tr> <td class="label">AC-907</td> <td>Research</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
...
IKKBETA Gene
Introduction <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">IKKBETA Gene</th> </tr> <tr> <td class="label">Gene Symbol</td> <td>IKBKB</td> </tr> <tr> <td class="label">Alternate Symbols</td> <td>IKKβ, IKK2</td> </tr> <tr> <td class="label">Full Name</td> <td>Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta</td> </tr> <tr> <td class="label">Chromosomal Location</td> <td>8p11.21</td> </tr> <tr> <td class="label">NCBI Gene ID</td> <td>3551</td> </tr> <tr> <td class="label">Ensembl ID</td> <td>ENSG00000105220</td> </tr> <tr> <td class="label">UniProt ID</td> <td>O14920</td> </tr> <tr> <td class="label">RefSeq mRNA</td> <td>NM_001190</td> </tr> <tr> <td class="label">Protein Length</td> <td>756 amino acids</td> </tr> <tr> <td class="label">Compound</td> <td>Stage</td> </tr> <tr> <td class="label">Bay 11-7082</td> <td>Preclinical</td> </tr> <tr> <td class="label">MLN120B</td> <td>Preclinical</td> </tr> <tr> <td class="label">PS-1145</td> <td>Preclinical</td> </tr> <tr> <td class="label">AC-907</td> <td>Research</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
IKBKB (Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta), also known as IKKβ , encodes a critical serine/threonine protein kinase that serves as the catalytic core of the IKK complex. This complex is essential for activating the [NF-κB](/entities/nf-kb) transcription factor, which plays a central role in inflammation, immune response, cell survival, and neurodegeneration. [@mercurio1997]
Overview IKKβ is the catalytic subunit of the IκB kinase (IKK) complex, which also includes IKKα (CHUK) and IKKγ (NEMO). The IKK complex phosphorylates IκBα, leading to its ubiquitination and degradation, thereby releasing NF-κB to translocate to the nucleus and activate target genes. Dysregulation of IKKβ/NF-κB signaling is implicated in chronic neuroinflammation, a hallmark of neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and ALS. [@karin2000]
Protein Structure The IKKβ protein contains several functional domains:
N-terminal kinase domain (aa 1-300) : Catalytic core with serine/threonine kinase activity
Leucine zipper (aa 300-400) : Mediates homodimerization and heterodimerization with IKKα
Helix-loop-helix domain (aa 400-500) : Structural role in complex formation
C-terminal NEMO-binding domain (aa 700-756) : Essential for interaction with IKKγ/NEMO
Multiple phosphorylation sites : Ser177, Ser181 (activation loop), and others for regulation
Normal Function
NF-κB Activation Pathway IKKβ is the primary kinase responsible for canonical NF-κB activation:
Signal reception : Pro-inflammatory cytokines (TNF-α, IL-1β), pathogens (LPS), or stress signals activate IKK complex
IKKβ activation : IKKβ is phosphorylated at Ser177 and Ser181 by upstream kinases (NIK, TAK1)
IκBα phosphorylation : IKKβ phosphorylates IκBα at Ser32 and Ser36
Ubiquitination : Phosphorylated IκBα is polyubiquitinated and degraded by the proteasome
NF-κB release : NF-κB (p65/p50 dimer) translocates to the nucleus
Cellular Functions
Inflammatory response : Activates transcription of pro-inflammatory genes
Cell survival : Promotes expression of anti-apoptotic genes (Bcl-2, Bcl-xL)
Immune regulation : Essential for lymphocyte development and function
Stress response : Participates in cellular stress signaling
Expression Pattern IKBKB is widely expressed across tissues:
Brain : [Neurons](/entities/neurons), [astrocytes](/entities/astrocytes), [microglia](/cell-types/microglia-neuroinflammation), oligodendrocytes
Immune system : T cells, B cells, macrophages
Peripheral tissues : Liver, lung, kidney, heart
Cellular localization : Primarily cytoplasmic, translocates to nucleus upon activation
Role in Neurodegenerative Diseases
Alzheimer's Disease IKKβ-mediated NF-κB activation plays a complex role in AD:
Chronic neuroinflammation : IKKβ is chronically activated in AD brain, driving pro-inflammatory cytokine production (IL-1β, TNF-α, IL-6)
Amyloid-β response : [Aβ](/proteins/amyloid-beta) plaques activate IKKβ/NF-κB pathway in surrounding microglia and astrocytes
Neuronal dysfunction : Constitutive NF-κB activation can impair synaptic plasticity and cognitive function
Therapeutic targeting : IKKβ inhibitors have shown promise in preclinical AD models
Parkinson's Disease In PD, IKKβ contributes to:
Microglial activation : MPTP, [α-synuclein](/proteins/alpha-synuclein), and other PD triggers activate IKKβ in microglia
Dopaminergic neuron death : Chronic inflammation accelerates dopaminergic degeneration
[Blood-brain barrier](/entities/blood-brain-barrier) dysfunction : IKKβ-mediated inflammation affects BBB integrity
Amyotrophic Lateral Sclerosis (ALS)
Motor neuron vulnerability : IKKβ activation in motor neurons and glia
Glutamate excitotoxicity : NF-κB regulates glutamate transporter expression
Protein aggregation : IKKβ may influence [TDP-43](/mechanisms/tdp-43-proteinopathy) and SOD1 pathology
Multiple Sclerosis
Demyelination : IKKβ-driven inflammation contributes to oligodendrocyte death
Autoimmune response : T-cell activation through NF-κB pathway
Therapeutic Implications
IKKβ Inhibitors Several IKKβ inhibitors have been developed:
Challenges
Broad immunosuppression : Systemic IKKβ inhibition compromises immune function
BBB penetration : Many inhibitors don't effectively cross the blood-brain barrier
Compensatory pathways : Alternative NF-κB activation routes may bypass IKKβ
Interactions and Signaling
Upstream Regulators
TAK1 : Transforming growth factor β-activated kinase 1 phosphorylates IKKβ
NEMO/IKKγ : Scaffold protein essential for IKK complex stability
RIP1 : Receptor-interacting protein 1 links TNFR signaling to IKK
Downstream Targets
IκBα : Primary substrate, inhibitor of NF-κB
p65/RelA : NF-κB subunit phosphorylated by IKKβ
IkBε : Alternative IκB isoform
Protein Complexes
IKK core complex : IKKα-IKKβ-IKKγ (NEMO)
Canonical NF-κB : p50/p65 heterodimer
Signalosomes : TRAF6, TAB2/3 complexes
Clinical Significance
Genetic Associations
Autoimmune diseases : IKBKB polymorphisms linked to psoriasis, inflammatory bowel disease
Immunodeficiency : NEMO mutations affect IKKβ function
Cancer : Overexpression in various malignancies
Biomarkers
Phospho-IKKβ : Marker of NF-κB activation status
NF-κB target genes : IL-6, TNF-α, COX-2 as inflammation markers
See Also
[NF-κB Signaling Pathway](/mechanisms/nf-kb-signaling-neuroinflammation)mechanisms/nf-kb-signaling-neuroinflammation)
[Neuroinflammation](/mechanisms/neuroinflammation)
[TNF-α Signaling](/mechanisms/tnf-alpha-signaling)
[Microglial Activation](/mechanisms/microglial-activation)mechanisms/microglial-phagocytosis)
[Alzheimer's Disease Mechanisms](/diseases/alzheimers-disease)
[Parkinson's Disease Mechanisms](/diseases/parkinsons-disease)
External Links
[NCBI Gene: IKBKB](https://www.ncbi.nlm.nih.gov/gene/3551)
[UniProt: IKBKB](https://www.uniprot.org/uniprot/O14920)
[Ensembl: IKBKB](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000105220)
[GeneCards: IKBKB](https://www.genecards.org/cgi-bin/carddisp.pl?gene=IKBKB)
[PDB: IKKβ Structure](https://www.rcsb.org/structure/3RZX)
Background The study of Ikkbeta Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Mercurio F, Murray BW, Shevchenko A, et al, IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation (1997)](https://pubmed.ncbi.nlm.nih.gov/9346482/)
[Karin M, Ben-Neriah Y, Phosphorylation meets ubiquitination: the control of NF-κB activity (2000)](https://pubmed.ncbi.nlm.nih.gov/10837071/)
[Hayden MS, Ghosh S, Signaling to NF-κB (2004)](https://pubmed.ncbi.nlm.nih.gov/15371334/)
[Ghosh S, Karin M, Missing pieces in the NF-κB puzzle (2002)](https://pubmed.ncbi.nlm.nih.gov/11983155/)
[Karin M, How NF-κB is activated: the role of the IκB kinase (IKK) complex (1999)](https://pubmed.ncbi.nlm.nih.gov/10602462/)
[Chen J, Chen ZJ, Regulation of NF-κB by ubiquitination (2013)](https://pubmed.ncbi.nlm.nih.gov/23312891/)
[Kaltschmidt B, Kaltschmidt C, NF-κB in the nervous system (2009)](https://pubmed.ncbi.nlm.nih.gov/20066108/)
[Mattson MP, Meffert MK, Roles for NF-κB in the nervous system: insights from experiments and models (2006)](https://pubmed.ncbi.nlm.nih.gov/16598663/)
Show full description